 MEI Pharma Inc NASDAQ: MEIP shares are plunging in Thursdays after-hours session after the company provided an investor update following a recent meeting with the U.S. Food and Drug Administration. During the meeting, the FDA informed MEI Pharma that a randomized trial would . 